Gene-Modified Human α/β-T Cells Expressing a Chimeric CD16-CD3ζ Receptor as Adoptively Transferable Effector Cells for Anticancer Monoclonal Antibody Therapy
Fumihiro Ochi(Mie University), Masaki Yasukawa(Ehime Prefectural University of Health Science)
Cited by 47
Related Papers
A single-chain antibody generation system yielding CAR-T cells with superior antitumor function
|Communications Biology|2021|33